Related references
Note: Only part of the references are listed.Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients
Wei-neng Feng et al.
TRANSLATIONAL ONCOLOGY (2018)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network
Michael J. McConnell et al.
SCIENCE (2017)
Single-cell transcriptomics to explore the immune system in health and disease
Michael J. T. Stubbington et al.
SCIENCE (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Liquid Biopsies, What We Do Not Know (Yet)
Alberto Bardelli et al.
CANCER CELL (2017)
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial
Masahiko Yanagita et al.
CLINICAL CANCER RESEARCH (2016)
Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
Felix Leung et al.
CLINICAL CHEMISTRY (2016)
Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
Max Schreuer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Integrated digital error suppression for improved detection of circulating tumor DNA
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer
Victoria Villaflor et al.
ONCOTARGET (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
Lynnette Fernandez-Cuesta et al.
EBIOMEDICINE (2016)
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Chiya Oshiro et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients
Antonio Marchetti et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
Use of Cell-free DNA to Screen for Down's Syndrome
Lyn S. Chitty
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
Kristina Warton et al.
BMC GENOMICS (2014)
The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
A. D. Nygaard et al.
BRITISH JOURNAL OF CANCER (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
Florent Mouliere et al.
MOLECULAR ONCOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Quantification of Cell-Free DNA in Normal and Complicated Pregnancies: Overcoming Biological and Technical Issues
Irina Manokhina et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
Sumitra Mohan et al.
PLOS GENETICS (2014)
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
Evan J. Lipson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Circulating cell free DNA: Preanalytical considerations
Safia El Messaoudi et al.
CLINICA CHIMICA ACTA (2013)
The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
Yahya I. Elshimali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies
Jacob A. Canick et al.
PRENATAL DIAGNOSIS (2013)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz et al.
NATURE (2012)
Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
Raquel Catarino et al.
PLOS ONE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Circulating Cell-Free DNA An Up-Coming Molecular Marker in Exercise Physiology
Sarah Breitbach et al.
SPORTS MEDICINE (2012)
Limits of Tumor Detectability in Nuclear Medicine and PET
Yusuf Emre Erdi
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY (2012)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Florent Mouliere et al.
PLOS ONE (2011)
Does the cell number 109 still really fit one gram of tumor tissue?
Ugo Del Monte
CELL CYCLE (2009)
Rethinking Screening for Breast Cancer and Prostate Cancer
Laura Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Non-invasive prenatal diagnosis by single molecule counting technologies
Rossa W. K. Chiu et al.
TRENDS IN GENETICS (2009)
Ontario institute offers new model of cancer research
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Breast cancer tumor growth estimated through mammography screening data
Harald Weedon-Fekjaer et al.
BREAST CANCER RESEARCH (2008)
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence:: A prospective study
Emmanuelle Gormally et al.
CANCER RESEARCH (2006)
Cell-free fetal DNA in maternal blood: kinetics, source and structure
FZ Bischoff et al.
HUMAN REPRODUCTION UPDATE (2005)
Share Paper
